¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"haemoglobin C disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
¿µ¹® venereal disease, sexually transmitted diseases ÇÑ±Û ¼ºº´
¼³¸í   
  º¸ÆíÀûÀ¸·Î ¼º±³ ¶Ç´Â ¼º±âÁ¢ÃË¿¡ ÀÇÇØ °É¸®´Â Á¢ÃË Àü¿°º´À¸·Î ¸Åµ¶, ÀÓÁú, ¹«¸¥±Ë¾ç, »ô±¼À°¾ÆÁ¾ µîÀ» ¸»ÇÑ´Ù. Ä¡·á´Â ¿øÀαտ¡ µû¸¥ ÀûÀýÇÑ Ç×»ý¿ä¹ýÀÌ´Ù.
¿µ¹® VDRL(venereal disease research laboratory) ÇÑ±Û ¼ºº´ ¿¬±¸½ÇÇè½Ç
¼³¸í   
  ¸Åµ¶±ÕÀÇ reagin¿¡ ´ëÇÑ Ç×ü. ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ¿Í Ä¡·áÈ¿°ú ÆÇÁ¤¿¡µµ »ç¿ëµÈ´Ù. ¸Åµ¶¿Ü¿¡µµ Àü½Å¼ºÈ«¹Ý¼º³¶Ã¢, ·ù¸¶Æ¼½º°üÀý¿° µî¿¡¼­µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù.
¿µ¹® hemolytic disease of newborn ÇÑ±Û ½Å»ý¾Æ¿ëÇ÷º´
¼³¸í   
  ½Å»ý¾Æ¿¡¼­ ÀûÇ÷±¸°¡ ºñÁ¤»óÀûÀ¸·Î ¸¹ÀÌ ÆÄ±«µÇ´Â º´À¸·Î Å¾ÆÀû¸ð±¸Áõ(erythroblastosis fetalis)¿Í °°Àº ¶æÀ¸·Î ¾²ÀδÙ. À̰ÍÀº ¾î¸Ó´Ï¿¡°Ô¼­ »ý»êµÈ ½Å»ý¾Æ³ª Å¾ÆÀÇ ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü°¡ Å¹ÝÀ» °Ç³Ê¿Í¼­ Å¾ÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÇÏ¿©¼­ »ý±â´Â ¿ëÇ÷¼ººóÇ÷À» À̸£´Â ¸». ÁŻý¾Æ³ª Å¾ÆÀÇ ÀûÇ÷±¸ÀÇ Ç×ü°¡ ¾î¸Ó´ÏÀÇ ¸ö¿¡¼­ »ý»êÀÌ µÇ°í À̰ÍÀ̠ŹÝÀ» ÅëÇØ¼­ Å¾ƿ¡°Ô ³Ñ¾î°¡¼­ Å¾ÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÀ» Çϰí ÀÌ Ç×ü¿Í °áÇÕÇÑ ÀûÇ÷±¸´Â ÆÄ±«°¡ µÇ¾î¼­ ºóÇ÷ÀÌ »ý±ä °ÍÀ» Å¾ÆÀû¸ð±¸ÁõÀ̶ó°í ÇÑ´Ù. À̰ÍÀº Rh Àû¸ð±¸Áõ(Rh erythroblastosis)¿Í ABO Àû¸ð±¸Áõ(ABO erythroblastosis)·Î ³ª´­ ¼ö°¡ ÀÖ´Ù.
¿µ¹® coronary artery disease ÇÑ±Û ½ÉÀ嵿¸Æº´
¼³¸í   
  ½ÉÀ嵿¸ÆÀ̶õ ½ÉÀå¿¡ Ç÷¾×À» °ø±ÞÇϴ µ¿¸ÆÀ» ¸»ÇÑ´Ù. ½ÉÀåµµ ´Ù¸¥ ±ÙÀ°°ú ¸¶Âù°¡Áö·Î Ç÷¾×À» °ø±Þ¹Þ¾Æ¾ß ¼öÃàÀ» ÇÒ ¼ö°¡ Àִ ±â°üÀ¸·Î ½ÉÀåÀÇ Ç÷¾×À» °ø±ÞÇϴ µ¿¸ÆÀ» ½ÉÀ嵿¸ÆÀ̶ó°í ÇÑ´Ù. ½ÉÀ嵿¸Æº´À̶õ ½ÉÀ嵿¸ÆÀÇ ³»°æÀÌ Á¼¾ÆÁ®¼­ »ý±â´Â ÁúȯÀ¸·Î ÇãÇ÷½ÉÀ庴(ischemic heart disease)À̶ó°íµµ ºÒ¸°´Ù. °ü»óµ¿¸ÆÀÌ Á¼¾ÆÁú °æ¿ì¿¡´Â ½ÉÀåÀ¸·Î °¡´Â Ç÷¾×ÀÇ ¾çÀÌ Àû¾îÁ®¼­ ½ÉÀå¿¡ ÃæºÐÇÑ Ç÷¾×ÀÌ °ø±ÞÀÌ µÇÁö ¸øÇϹǷΠ¿©·¯ °¡Áö º´ÀûÀΠÇö»óÀÌ »ý±ä´Ù. ½ÉÀ嵿¸ÆÀÌ Á¼¾ÆÁö´Â µ¥¿¡´Â ¿©·¯ °¡Áö ¿øÀÎÀÌ ÀÖÀ» ¼ö°¡ ÀÖÀ¸³ª ÁַΠ½ÉÀ嵿¸ÆÀÇ µ¿¸Æ°æÈ­Áõ¿¡ ÀÇÇÑ´Ù. µ¿¸Æ°æÈ­ÁõÀ̶õ µ¿¸ÆÀÇ ³»Ãþ¿¡ Áö¹æ°ú ÄÝ·¹½ºÅ׷ѷΠÀÌ·ç¾îÁø Á×Á¾(atheroma)°¡ »ý±â´Â ÁúȯÀ¸·Î Á×Á¾ÀÌ »ý±ä µ¿¸ÆÀº Á×Á¾ÀÌ Ç÷°üÀÇ ³»ºÎ·Î µ¹ÃâÇϰԠµÇ¾î¼­ Ç÷°üÀÇ ³»°æÀÌ ÀÛ¾ÆÁö°Ô µÈ´Ù.
  
  ½ÉÀ嵿¸Æº´Àº ±× Á¤µµ¿¡ µû¶ó¼­ Çù½ÉÁõ(angina pectoris)¿Í ½É±Ù°æ»öÁõ(myocardial infarction)À¸·Î ³ª´«´Ù. Çù½ÉÁõÀº ½ÉÀ嵿¸ÆÀÇ ºÎºÐÀû Æó¼â¿¡ ÀÇÇØ¼­ Æò»ó½Ã¿¡´Â Áõ»óÀÌ ¾øÁö¸¸ ½ÉÀåÀÌ ¸¹Àº È°µ¿À» ÇÒ °æ¿ì¿¡ ½ÉÀå¿¡ Çǰ¡ ÃæºÐÇÑ ¸¸Å­ °ø±ÞÀÌ µÇÁö ¾Ê¾Æ¼­ »ý±â´Â Áúº´À¸·Î Æò»ó½Ã¿¡ ½¯ °æ¿ì¿¡´Â ¾Æ¹« Áõ»óÀÌ ¾øÁö¸¸ ¿îµ¿À̳ª °ú½Ä µîÀÇ ¿øÀÎÀ¸·Î ½ÉÀåÀÌ ¸¹Àº ¿îµ¿À» ÇÒ °æ¿ì¿¡ ½ÉÀå¿¡ °ø±ÞµÇ´Â Ç÷¾×ÀÇ ¾çÀÌ ¸ðÀÚ¶ó¼­ Áõ»ó(´ë°³ °¡½¿ºÎÀ§¿¡ Áã¾îÂ¥´Â µíÇÑ ÅëÁõ)ÀÌ »ý±ä´Ù. ½É±Ù°æ»öÁõÀ̶õ ½ÉÀ嵿¸ÆÀÇ ¿ÏÀüÆó¼â¿¡ ÀÇÇØ¼­ ½ÉÀåÀÇ ±ÙÀ°ÀÌ Ç÷¾×À» ÀüÇô °ø±Þ¹ÞÁö ¸øÇؼ­ ½ÉÀåÀÇ ±ÙÀ°ÀÌ ½â´Â °æ¿ì¸¦ ¸»ÇÑ´Ù.
¿µ¹® heart disease ÇÑ±Û ½ÉÀ庴
¼³¸í   
  ¼øÈ¯±â Áúȯ Áß ½ÉÀåÀÇ º´. ÀϹÝÀûÀ¸·Î ½ÉÀåÇ÷°üÀ̳ª ½ÉÀåÀÇ º´µµ Æ÷ÇԵȴÙ. º´ÅÍÀÇ ºÎÀ§¿¡ ÀÇÇÑ º´¸®ÇغÎÇÐÀû ºÐ·ù¿Í º´Àο¡ ÀÇÇÑ ºÐ·ù°¡ ÀÖ´Ù. ÀüÀڴ ¼ö ½Ê ³â ÀüºÎÅÍ ¾²¿©Á® ¿ÔÀ¸³ª ±Ù³â¿¡ ¿Í¼­ º»ÁúÀûÀΠ¿øÀοä¹ýÀÌ °¡´ÉÇϰԠµÈ ÀÌÈĴ ÈÄÀÚÀÇ ºÐ·ù°¡ ÀÇÀǰ¡ À־ ¸¹ÀÌ ¾²À̰ԠµÇ¾ú´Ù. º´ÅÍ ºÎÀ§·Î´Â ½É³»¸·(ÆÇ¸·)-½ÉÀå±Ù-½ÉÀ帷, ±× ¹ÛÀÇ °ÍÀ» µé ¼ö ÀÖÀ¸¸ç, °¢°¢ ½É³»¸·¿°-½ÉÀåÆÇ¸·Áõ-½É±Ù¿°-½É±Ù°æ»ö-½ÉÀ帷¿°-¼±Ãµ¼º ½ÉÀ庴(½ÉÀå±âÇü) µîÀÌÆ÷ÇԵȴÙ. º´Àκ°¿¡¼­´Â ½ÉÀå±âÇüÀ» ºñ·ÔÇÏ¿© ·ù¸¶Ä¡½º ½ÉÀ庴-¸Åµ¶¼º ½ÉÀ庴-°íÇ÷¾Ð¼º ½ÉÀ庴-½ÉÀ嵿¸Æ°æÈ­¼º ½ÉÀ庴-Æó¼º½ÉÀå-¼¼±Õ¼º ½É³»¸·¿°-½ÉÀå½Å°æÁõ µîÀ¸·Î ³ª´©¾îÁö¸ç, ºÎÁ¤¸ÆÀ̳ª ¹æ½ÇÂ÷´Ü µîÀÇ ÀÚ±ØÀüµµ°èÀÇ Àå¾Ö¿¡ ÀÇÇÑ °Íµµ Áõ¼¼ÀÇ Çϳª·Î º¼ ¼ö ÀÖ´Ù. ½ÉÀ庴Àº ÀÚ°¢ÀûÀ¸·Î´Â ¹«Áõ¼¼ÀΠ°Í¿¡¼­ºÎÅÍ ½ÉÀå±â´É»ó½Ç·Î È£Èí°ï¶õ±îÁö ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • cold agglutinin disease
    Àú¿ÂÀÀÁýº´
  • collagen disease
    Äݶó°Õº´
  • collagen-vascular disease
    Äݶó°ÕÇ÷°üº´, ±³¿øÇ÷°üº´
  • comb disease
    ´ßº­½½º´
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined system disease
    º¹ÇÕ°èÅ뺴
  • combined valvular disease
    º¹ÇÕÆÇ¸·º´
  • communicable disease
    Àü¿°º´
  • communicable disease control
    Àü¿°º´°ü¸®
  • complicating disease
    ÇÕº´Áúȯ
  • compressed-air disease
    °¨¾Ðº´
  • congenital heart disease
    ¼±Ãµ½ÉÀ庴
  • connective tissue disease
    °áÇÕÁ¶Á÷º´
  • constitutional disease
    üÁúº´
  • constrictive heart disease
    ÇùÂø½ÉÀ庴
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • pneumatic hammer disease
    ¾ÐÂø°ø±âÇØ¸ÓÁõ
  • primary cholestatic liver disease
    ÀÏÂ÷¾µ°³ÁóÁ¤Ã¼°£Áúȯ, ÀÏÂ÷´ãÁóÁ¤Ã¼°£Áúȯ
  • professional disease
    Á÷¾÷º´
  • Raynaud¡¯s disease
    ·¹À̳뺴
  • renal disease
    ÄáÆÏº´, ½ÅÀ庴
  • rheumatic disease
    ·ù¸¶Æ¼½ºº´
  • rice disease
    (¢¡ beriberi) °¢±â
  • silo filler's disease
    ¸¶ÃÊÀúÀå°í³óºÎº´
  • spinal disease
    ô¼öº´
  • storage disease
    ÃàÀûº´
  • systemic disease
    Àü½Åº´
  • Takayasu's disease
    ´ÙÄ«¾ß¼öº´
  • thin basement membrane disease
    ¾ãÀº¹Ù´Ú¸·º´, ¾ãÀº±âÀú¸·º´
  • thin glomerular basement disease
    ¾ãÀºÅ丮¹Ù´Ú¸·º´, ¾ãÀº»ç±¸Ã¼±âÀú¸·º´
  • tropical disease
    ¿­´ëº´
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • central core disease
    Áß½ÉÇÙº´
  • cerebrovascular disease
    ³úÇ÷°üº´, ³úÇ÷°üÁúȯ
  • cervical disease
    Àڱøñº´, ÀڱðæºÎº´, ÀڱðæºÎÁúȯ
  • chronic granulomatous disease
    ¸¸¼ºÀ°¾ÆÁ¾º´
  • chronic obstructive pulmonary disease
    ¸¸¼ºÆó¼âÆóÁúȯ, ¸¸¼ºÆó¼âÆóº´
  • climatic disease
    ±âÈĺ´
  • cold agglutinin disease
    Àú¿ÂÀÀÁýº´
  • cold hemagglutinin disease
    Àú¿ÂÇ÷±¸ÀÀÁý¼Òº´, ÇÑ·©ÀûÇ÷±¸ÀÀÁýº´
  • collagen disease
    ¾Æ±³Áúº´
  • collagen-vascular disease
    ¾Æ±³ÁúÇ÷°üº´, ±³¿øÇ÷°üº´
  • comb disease
    ´ßº­½½º´
  • combined immunodeficiency disease
    º¹Çո鿪°áÇ̺´
  • combined system disease
    º¹ÇÕ°èÅ뺴
  • combined valvular disease
    º¹ÇÕÆÇ¸·Áõ, º¹ÇÕÆÇ¸·º´
  • communicable disease
    Àü¿°º´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Chagas-disease =Brazilian trypano somia sis
    »þ°¡½ºº´ ¡ì¾Æ¸Þ¸®Ä«Æ®¸®ÆÄ ³ë¼Ò¸¶Áõ¡í.
  • Charcot-Guinon disease
    ¼£Äà ±â³í º´
  • Charcot-Marie-Tooth disease
    »þ¸£ÄÚ-¸¶¸®-Åõ½ºº´.
  • Charcots disease
    »þ¸£ÄÚ º´(¡­Ü»).
  • Charlouis-disease
    »þ¸¦·çÀ̺´.
  • Chesters disease
    ü½ºÅͺ´.
  • Chiari-Frommel disease
    Ű¾Æ¸®ÇÁ·Ò¸áº´.
  • Chicago disease
    ½ÃÄ«°íº´.
  • Christmas disease
    Å©¸®½º¸¶½ºº´
  • Christmas disease
    Å©¸®½º¸¶½º º´
  • Christmas disease=hemophilia B
    Å©¸®½º¸¶½ºº´=Ç÷¿ìº´ B
  • Clostridial disease
    Ŭ·Î½ºÆ®¸®µð¿òº´
  • Coats disease
    ÄÚ¿ìÃ÷º´
  • Coats disease
    ÄÚ¿ìÃ÷º´
  • Corvisart s disease
    ÄÚ¸£ºñÀÚ¸£º´.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • alkali disease =alkalosis
    ¾ËÄ®¸®º´ ¾ËÄ®¸®(Ç÷)Áõ .
  • allergic disease
    ¾Ë·¹¸£±â¼º Áúȯ, ¾Ë·¹¸£±âº´
  • allergic disease
    ¾Ë·¹¸£±â(¼º) Áúȯ
  • allergic respiratory disease
    ¾Ë·¹¸£±â¼º È£Èí±âº´
  • allergic skin disease
    ¾Ë·¹¸£±â(¼º)ÇǺΠÁúȯ
  • allergic skin disease
    ¾Ë·¹¸£±â[¼º] ÇǺκ´
  • alpha (¥á) chain disease
    ¾ËÆÄ»ç½½º´, ¾ËÆÄ¼âº´
  • alpha chain disease
    ¾ËÆÄ¼âº´(¡­áðÜ»).
  • alpha chain disease
    ¾ËÆÄ¼âÁúȯ
  • alpha-chain disease
    ¾ËÆÄ¼â Áúȯ(¡­áð òðü´)
  • alports syndrome(disease)
    ¾ËÆ÷Æ® ÁõÈıº(º´)(¡­ñøý¦ÏØ)
  • aluminium dust disease
    ¾Ë·ç¹Ì´½°¡·çº´(ÊÙËÓ).
  • alzheimers disease
    ¾ËÂêÇÏÀ̸Ӻ´(¡­Ü»)
  • amaurotic familial idiocy =Tay-Sachs disease
    °¡Á·¼º Èæ³»Àå ¹éÄ¡(Ê«ðéàõýÙÒ®î¡ÛÜöÁ).
  • amaurotic familial idiocy =Tay-Sachs disease
    °¡Á·¼ºÈæ¾Ï½Ã¹éÄ¡(Ê«ðéàõýÙÒ®î¡ÛÜöÁ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • maple syrup urine disease
    ´Üdz½Ã·´´¢Áúȯ(Òãòðü´)
  • metabolic disease
    ´ë»çÁúȯ(ÓÛÞóòðü´)
  • molecular disease
    ºÐÀÚº´(ÝÂí­Ü»)
  • mucopolysaccharide storage disease
    ¹ÂÄÚ´Ù´çÁú(ÒýÓØòõ)ÀúÀåÁúȯ(îÍíúòðü´)
  • Niemann-Pick disease
    ´Ï¸¸-ÇÈ Áúȯ(òðü´)
  • Parkinson's disease
    ÆÄŲ¼Õ º´(Ü»)
  • Pompe's disease
    ÆûÆä Áúȯ(òðü´)
  • Refsum's disease
    ·¾¼û Áúȯ(òðü´)
  • Sandhoff's disease
    ¼¾µµÇÁ Áúȯ(òðü´)
  • sickle cell disease
    ³´¼¼Æ÷(á¬øà)Áúȯ(òðü´)
  • Tangier disease
    źÁö¿¡¸£ Áúȯ(òðü´)
  • Tay-Sachs disease
    ŸÀÌ-»è½º Áúȯ(òðü´)
  • von Gierke's disease
    Æù ±â¿¡¸£ÄÉ Áúȯ (òðü´)
  • von Willebrand's disease
    Æù ºô·¹ºê¶õÆ® Áúȯ (òðü´)
  • Wilson's disease
    Àª½¼ Áúȯ (òðü´)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • ischemic heart disease
    ÇãÇ÷¼º ½ÉÁúȯ
  • Letterer-Siwe disease
    ·¹Å×·¯-½Ã¿þº´
  • marble bone disease
    ´ë¸®¼®°ñº´
  • metabolic disease
    ´ë»ç¼ºÁúȯ
  • mitral valvular disease
    ½Â¸ðÆÇ¸·Áúȯ
  • neoplastic disease
    Á¾¾ç¼ºÁúȯ
  • neuromuscular disease
    ½Å°æ±ÙÀ° Áúȯ
  • Niemann-Pick disease
    ´ÏÀ̸¸-ÇȺ´
  • nutritional deficiency disease
    ¿µ¾ç°áÇÌÁõ
  • obstructive pulmonary disease
    Æó¼â¼ºÆóÁúȯ
  • occupational disease
    Á÷¾÷º´
  • Paget's disease
    ÆÄÁ¦Æ®º´
  • parkinson's disease
    ÆÄŲ½¼º´
  • pelvic inflammatory disease
    °ñ¹Ý¿°Áúȯ
  • peripheral vascular disease
    ¸»ÃÊÇ÷°üÁúȯ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ARD absolute reaction of degeneration; acute radiation disease; acute respiratory disease; adult respira...
DD dangerous drug; data definition; day of delivery; degenerated disc; degenerative disease; delusional...
DDD AV universal [pacemaker]; defined daily dose; degenerative disc disease; dehydroxydinaphthyl disulfi...
ND Doctor of Naturopathy; nasal deformity; natural death; Naval Dispensary; neonatal death; neoplastic ...
AR   1) Aortic Regurgitation
    = AI
  Echo¼Ò°ß
 &...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FHb free haemoglobin
MCH mean cell haemoglobin
AIDS Acquired Immune Deficiency Disease Syndrome
AIDS Acquired Immunodeficiency Disease
ACDK Acquired cystic disease of the kidney
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Ballingall's disease
    ¹ß¸µ°¥ º´
  • Bamberger's disease
    ¹ãº£¸£°Å º´
    ´Ù¸®ÀÇ µµ¾à °æ·Ã ¶Ç´Â ƽ.
  • Banti's disease
    ¹ÝƼ º´
    Ãʱ⿡´Â ºñÁ¾ ¹× ¹üÇ÷±¸ °¨¼ÒÁõÀ» µ¿¹ÝÇÏ´Â ºñÀåÀÇ ¿ø¹ß¼º ÁúȯÀ¸·Î ±â·ÏµÇ¾úÀ¸³ª, ÈÄ¿¡ ¹®¸Æ¾Ð Ç×Áø¿¡ ÀÇÇÑ ÀÌÂ÷ÀûÀÎ °ÍÀ¸·Î ÀÎÁ¤µÇ¾ú´Ù.
  • Barcoo disease
    ¹Ù¸£Äíº´
    µ¿ÀǾî=desert sore.
  • Barthelemy's disease
    ¹Ù¸£ÅÚ·¹¹Ì º´
    ¾ó±¼ÀÇ °áÇÙ¼º µÎâ ºñ½ÁÇÑ ÁÂâ.
  • Basedow's disease
    ¹Ù¼¼µµ¿ì º´
    µ¿ÀǾî=Graves' disease. °©»ó¼± ±â´ÉÇ×ÁøÁõ.
  • Bazin's disease
    ¹ÙÁø º´
    µ¿ÀǾî=erythema induratum.
  • Beard's disease
    º£¾îµå º´
    µ¿ÀǾî=neurasthenia.
  • Beau's disease
    º¸¿ì º´
    µ¿ÀǾî=cardiac insufficiendy.
  • Bernard-Soulier disease
    º£¸£³ª¸£-¼ú¸®¿¡ º´, Bernard-Soulier º´
    Å©±â¿Í ÇüŰ¡ ´Ù¾çÇÑ Ç÷¼ÒÆÇÀ» Ư¡À¸·Î ÇÏ´Â »ó¿°»öü ¿­¼º À¯Àü¼º ÁúȯÀ¸·Î, Ç÷¼ÒÆÇ ¸·Àº Ç÷Àå vWF
  • Bernhardt's disease
    º£¸¥Çϸ£Æ® º´
    µ¿ÀǾî=meralgia
  • Best's disease
    º£½ºÆ® º´
    µ¿ÀǾî=congenital macular degeneration.
  • black disease
    Èæ»ö º´
    ¾çÀÇ Àü¿°¼º ±«»ç¼º °£¿°. ¹Ì±¹, ¿À½ºÆ®·¹Àϸ®¾Æ¿¡¼­ÀÇ ¾çÀÇ Ä¡»çº´ÀÌ¸ç ¶§¶§·Î »ç¶÷¿¡°Ôµµ »ý±ä´Ù. °£ÀåÀÇ ±«»ç°¡ ±× Ư¡ÀÌ¸ç ³ëºñ±Õ¿¡ ÀÇÇÏ¿© ÀϾ´Ù.
  • bleeder's disease
    Ç÷¿ìº´
    ÃâÇ÷À» Àß ÀÏÀ¸Å°°Å³ª ÃâÇ÷ ¼ÒÁúÀÌ ÀÖ´Â Áúº´.
  • Blocq's disease
    ºí·Ï º´
    µ¿ÀǾî=astasia, abasia.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
haemoglobin I An abnormal Hb with a single a chain substitution, molecular formula a216Lys→Glub2A; a thalassaemia-like syndrome has been found in individuals heterozygous for both Hb I and alpha-thalassaemia genes, with formation of about 70% Hb I.
(05 Mar 2000)
haemoglobin J <chemical> A group of abnormal haemoglobins with similar electrophoretic characteristics. They have faster electrophoretic mobility and different amino acid substitutions in either the alpha or beta chains than normal adult haemoglobin. Some of the variants produce haematologic abnormalities, others result in no clinical disorders.
Chemical name: Haemoglobin J
(12 Dec 1998)
haemoglobin JCapetown An abnormal Hb with a single a chain substitution, molecular formula a292Arg&rarr;Glnb2A; heterozygotes have polycythemia because of increased oxygen affinity of this Hb.
(05 Mar 2000)
haemoglobin Kansas An abnormal Hb of molecular formula a2Ab2102Asn&rarr;Thr; found in association with familial cyanosis due to decreased oxygen affinity of this Hb.
(05 Mar 2000)
haemoglobin Lepore A group of abnormal Hb's with normal a chains, but the non-a chains consist of the N-terminal portion of the d chain joined to the C-terminal portion of the b chain, apparently as the result of nonhomologous pairing and crossing over between the genes for b and d chains. The major types are Hb LeporeBoston (identical to Hb LeporeWashington), Hb LeporeHollandia, and Hb LeporeBaltimore, which differ in the region of crossing over (d87-b116, d22-b50, and d50-b86, respectively). Heterozygotes form about 10% Hb Lepore, normal amounts of Hb A2, and moderately increased amounts of Hb F and usually have mild anaemia, microcytosis, and hypochromia; homozygotes form only Hb Lepore and Hb F and have severe anaemia.
Compare: haemoglobin Anti-Lepore.
(05 Mar 2000)
haemoglobin M <chemical> A group of abnormal haemoglobins in which amino acid substitutions take place in either the alpha or beta chains but near the haem iron. This results in facilitated oxidation of the haemoglobin to yield excess methemoglobin which leads to cyanosis.
Chemical name: Haemoglobin M
(12 Dec 1998)
haemoglobin Portland A form of embryonic haemoglobin containing the &zeta; chains of haemoglobin Gower-1 and the g chains of Hb F, thus having the formula &zeta;2g2; essentially disappears by the third month of pregnancy.
Compare: haemoglobin Gower-1, haemoglobin Gower-2.
(05 Mar 2000)
haemoglobin Rainier An abnormal Hb of the molecular formula a2Ab2145Tyr&rarr;Cys; heterozygotes have polycythemia because of increased oxygen affinity of this Hb.
(05 Mar 2000)
haemoglobin S <haematology> Haemoglobin S is an abnormal version of the protein haemoglobin.
The sixth amino acid of the normal beta chain, glutamic acid, is replaced by valine with gluconic acid. This mutation causes the red blood cell to take on a sickle shape, and is the cause of the sickle cell trait condition (when the individual is heterozygous for this mutant haemoglobin) and the disease of sickle cell anaemia (when the individual is homozygous for this mutant haemoglobin).
(09 Oct 1997)
haemoglobin, sickle An abnormal haemoglobin resulting from the substitution of valine for glutamic acid at position 6 of the beta chain of the globin moiety. The heterozygous state results in sickle cell trait, the homozygous in sickle cell anaemia.
(12 Dec 1998)
haemoglobin Yakima An abnormal Hb of the molecular formula a2Ab299Asp&rarr;His; heterozygotes have polycythemia because of increased oxygen affinity of this Hb.
(05 Mar 2000)
hereditary persistence of foetal haemoglobin <haematology> Hereditary persistence of foetal haemoglobin is a genetic condition where adult types of haemoglobin fail to develop and the types of haemoglobin the individual had as a foetus remains present well past the point when they would normally have stopped being produced.
(09 Oct 1997)
sickle cell haemoglobin <haematology> Haemoglobin S is an abnormal version of the protein haemoglobin.
The sixth amino acid of the normal beta chain, glutamic acid, is replaced by valine with gluconic acid. This mutation causes the red blood cell to take on a sickle shape, and is the cause of the sickle cell trait condition (when the individual is heterozygous for this mutant haemoglobin) and the disease of sickle cell anaemia (when the individual is homozygous for this mutant haemoglobin).
(09 Oct 1997)
oxygenated haemoglobin <physiology> See Hemoglobin.
Origin: Oxy- + haemoglobin, hemoglobin.
Source: Websters Dictionary
(01 Mar 1998)
embryonic haemoglobin See: haemoglobin Gower-1, haemoglobin Gower-2.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • heart disease
    ½ÉÀ庴
  • hoof and mouth disease
    =FOOT AND MOUTH DISEASE
  • industrial disease
    (ÀÇ)Á÷¾÷º´
  • kashinBeck disease
    ij½Åº¤º´(À½·á¼ö ÁßÀÇ À¯±â»ê¿¡ ÀÇÇÑ »ÀÀÇ º¯Çü)
  • kissing disease
    Àü¿°¼º ´ÜÇÙÁõ;Ű½º º´
  • molecular disease
    ºÐÀÚº´
  • mosaic disease
    ¸ðÀÚÀÌÅ© º´(½Ä¹°ÀÇ Àü¿°º´)
  • occupational disease
    Á÷¾÷º´
  • parkinsons disease
    ÁøÀü ¸¶ºñ
  • pind disease
    Áö´Üµ¿ÅëÁõ(À¯¾Æº´)
  • pink disease
    Áö´Üµ¿Åë
  • pompe's disease
    ÆûÆäº´
  • potts disease
    Æ÷Æ®º´;ôÃß Ä«¸®¿¡½º
  • psychosomatic disease
    Á¤½Å ½Åü (½É½Å) Áõ
  • pullet disease
    X;=BLUE COMB
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á